Bass, Berry & Sims attorney Jeff Davis authored an article for the American Health Law Association (AHLA) discussing the Health Resources and Services Administration’s (HRSA) approval of a new 340B Rebate Pilot Program. Under the Pilot Program, drug manufacturers will be allowed to offer 340B-discounted drug prices through rebates for ten approved drugs in 2026. … Continued
| less than a minute read
Jeff Davis Discusses HRSA Approval of 340B Drug Rebate Plan
Get in touch
Get in touch
Get in touch
Get in touch
Latest Insights
/Passle/68adf618fb5257a156b22ed3/SearchServiceImages/2026-05-21-13-15-48-560-6a0f0584f260b6abe3441334.jpg)
/Passle/68adf618fb5257a156b22ed3/SearchServiceImages/2026-05-20-14-03-41-846-6a0dbf3d8c3558e305c11c73.jpg)
/Passle/68adf618fb5257a156b22ed3/SearchServiceImages/2026-05-15-18-22-48-833-6a076478e2201c8d90c8057e.jpg)